Errol B. Desouza
Director, IDEXX Laboratories, Inc.
Companies
- Alector (United States)Board member Mar 21, 2024 to now1
- Royalty Pharma plcBoard member Jun 15, 2020 to now2
- Korsana Biosciences, Inc.Board member May 19, 2021 to Dec 4, 20233
- GYRE THERAPEUTICS, INC.Board member Apr 11, 2006 to Oct 5, 20214
- ALBIREO PHARMA, INC.Board member Apr 2, 2010 to Oct 2, 20155
- ALBIREO PHARMA, INC.Chief executive officer Apr 2, 2010 to Oct 2, 20155
- PALATIN TECHNOLOGIES INCBoard member Jul 5, 2006 to Jul 23, 20106
- ALBIREO PHARMA, INC.President Apr 2, 2010 to Apr 2, 20105
- IDEXX Laboratories, Inc.Board member Feb 1, 2006 to May 1, 20097
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Royalty Pharma plc RPRX81,352 shares8$4.9M at $60.48May 13, 2025
- Korsana Biosciences, Inc. KRSA30,000 shares9$975.3K at $32.51Nov 30, 2023
- Alector (United States) ALEC98,650 shares10$190.9K at $1.94Jun 17, 2026
- GYRE THERAPEUTICS, INC. GYRE29,801 shares11$183.0K at $6.14Oct 1, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 17, 2026Granted 28,700 shares of Alector (United States)10
- Jun 11, 2025Granted 28,700 shares of Alector (United States)12
- May 13, 2025Granted 7,614 shares of Royalty Pharma plc8
- Jun 7, 2024Granted 9,293 shares of Royalty Pharma plc13
- Mar 19, 2024Granted 41,250 shares of Alector (United States)14
- Nov 30, 2023Granted 30,000 shares of Korsana Biosciences, Inc.9
- Nov 30, 2023Granted 20,000 shares of Korsana Biosciences, Inc.9
- Jun 23, 2023Granted 7,747 shares of Royalty Pharma plc15
- Jun 24, 2022Granted 6,328 shares of Royalty Pharma plc16
- Oct 1, 2021Granted 3,588 shares of GYRE THERAPEUTICS, INC.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARRoyalty Pharma plc, Board member
- 3
- 4
- 5SEC EDGARALBIREO PHARMA, INC., Board member
- 6
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARForm 4 filed Jun 12, 2025
- 13SEC EDGARForm 4 filed Jun 10, 2024
- 14SEC EDGARForm 4 filed Mar 21, 2024
- 15SEC EDGARForm 4 filed Jun 26, 2023
- 16SEC EDGARForm 4 filed Jun 24, 2022